Deletion of Cdkn1b ameliorates hyperglycemia by maintaining compensatory hyperinsulinemia in diabetic mice
The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
The protein p27(Kip1) regulates cell cycle progression in mammals by inhibiting the activity of cyclin-dependent kinases (CDKs). Here we show that p27(Kip1) progressively accumulates in the nucleus of pancreatic beta cells in mice that lack either insulin receptor substrate 2 (Irs2(-/-)) or the long form of the leptin receptor (Lepr(-/-) or db/db). Deletion of the gene encoding p27(Kip1) (Cdkn1b) ameliorated hyperglycemia in these animal models of type 2 diabetes mellitus by increasing islet mass and maintaining compensatory hyperinsulinemia, effects that were attributable predominantly to stimulation of pancreatic beta-cell proliferation. Thus, p27(Kip1) contributes to beta-cell failure during the development of type 2 diabetes in Irs2(-/-) and Lepr(-/-) mice and represents a potential new target for the treatment of this condition.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The cell cycle inhibitor p27, a marker of senescence, increases in pancreatic β-cells in genetic mouse models of type 2 diabetes, and p27 deletion in those mice increased insulin secretion and islet mass through increased proliferation (64).”
From Cellular Senescence in Type 2 Diabetes: A Therapeutic Opportunity (2015) · cites this paper as [64]
In the citing paper
“For instance, when cell cycle arrest is induced specifically in β-cells by overexpression of p27 [24] or by deletion of Cdk4 postnatally, β-cell mass decreases or fails to expand, which would not be the case if neogenesis or transdifferentiation were major sources of new β-cells [25,26].”
From Expansion of β-cell mass in response to pregnancy (2010) · cites this paper as [24]
Citations
Cites
Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
CDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor
Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J., & Greenberg, M. E. (1999) · Cell · doi:10.1016/s0092-8674(00)80595-4 · Cited by 5,594 · cited 1×
“This effect of Akt is mediated by the transcriptional regulator Foxo1 (refs”
Backgroundβ-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011 · cited 1×
“The mass of pancreatic islets is also reduced in individuals with this conditio”
BackgroundA mutation in the human leptin receptor gene causes obesity and pituitary dysfunction
Clément, K., Vaisse, C., Lahlou, N., Cabrol, S., Pelloux, V., Cassuto, D., Gourmelen, M., Dina, C., Chambaz, J., Lacorte, J.-M., et al. (1998) · Nature · doi:10.1038/32911 · Cited by 2,346
Abnormal splicing of the leptin receptor in diabetic mice
Lee, G.-H., Proenca, R., Montez, J. M., Carroll, K. M., Darvishzadeh, J. G., Lee, J. I., & Friedman, J. M. (1996) · Nature · doi:10.1038/379632a0 · Cited by 2,327 · cited 1×
“These mice develop obesity because of hyperphagia, decreased energy expenditure and preferential partitioning of calories into adipose tissue triglyceride”
BackgroundChen, H., Charlat, O., Tartaglia, L. A., Woolf, E. A., Weng, X., Ellis, S. J., Lakey, N. D., Culpepper, J., More, K. J., Breitbart, R. E., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81294-5 · Cited by 2,214
Pagano, M., Tam, S. W., Theodoras, A. M., Beer-Romero, P., Del Sal, G., Chau, V., Yew, P. R., Draetta, G. F., & Rolfe, M. (1995) · Science · doi:10.1126/science.7624798 · Cited by 1,817 · cited 1×
“, resulting in its degradation by the ubiquitin-proteasome pathwa”
BackgroundDisruption of IRS-2 causes type 2 diabetes in mice
Withers, D. J., Gutierrez, J. S., Towery, H., Burks, D. J., Ren, J.-M., Previs, S., Zhang, Y., Bernal, D., Pons, S., Shulman, G. I., et al. (1998) · Nature · doi:10.1038/36116 · Cited by 1,775 · cited 1×
“Irs2-deficient ( Irs2 −/− ) mice do not maintain islet mass in the face of hepatic insulin resistanc”
BackgroundSelf-citationNakayama, K., Ishida, N., Shirane, M., Inomata, A., Inoue, T., Shishido, N., Horii, I., Loh, D. Y., & Nakayama, K.-I. (1996) · Cell · doi:10.1016/s0092-8674(00)81237-4 · Cited by 1,547
Self-citation
Cited by
Items 101–200 of 218
Nakamura, K., Sakaue, H., Nishizawa, A., Matsuki, Y., Gomi, H., Watanabe, E., Hiramatsua, R., Tamamori‐Adachi, M., Kitajima, S., Noda, T., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802589200 · Cited by 43
Self-citationVasavada, R. C., Cózar‐Castellano, I., Sipula, D., & Stewart, A. F. (2006) · Diabetes · doi:10.2337/db06-0517 · Cited by 40
“Conversely, the observations that loss or inactivation of cell cycle inhibitors such as p18, p21, p27, p53, or p57 is associated with -cell cycle progression (12–15), whereas overexpression of p27 is associated with cell cycle slowing or arrest (14), has also been interpreted as supporting a key role for pRb in the co…”
BackgroundSkp2 Is Required for Incretin Hormone-Mediated β-Cell Proliferation
Tschen, S.-I., Georgia, S. K., Dhawan, S., & Bhushan, A. (2011) · Molecular Endocrinology · doi:10.1210/me.2011-1119 · Cited by 35
“Exendin-4 promotes -cell replication in db/db mice by promoting degradation of p27 The nuclei of -cells of Irs2 / mice and mice lacking the long form of the leptin receptor (Lepr / or db/db) show progressive accumulation of p27 and decreased -cell proliferation, resulting in the inability of the pancreas to respond to…”
BackgroundPost-transcriptional regulation in metabolic diseases
Kim, W., & Lee, E. K. (2012) · RNA Biology · doi:10.4161/rna.20091 · Cited by 35
Ma, X., Guan, Y., & Hua, X. (2014) · Journal of Diabetes · doi:10.1111/1753-0407.12161 · Cited by 38
“Deletion of p27cip1/kip1 (p27 hereafter), a cyclin-dependent kinase inhibitor, blocks development of diabetes in db/db mice, partly by increasing the number of β cells.(74) Deletion of Lkb1, a tumor suppressor involved in AMP kinase activation, promotes β-cell proliferation and ameliorates glucose intolerance.”
BackgroundJoshi, H. R., Vastrad, B. M., Joshi, N., Tengli, A., Vastrad, C. M., & Kotturshetti, I. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.628907 · Cited by 40
Inhibition of PHLPP1/2 phosphatases rescues pancreatic β-cells in diabetes
Lupše, B., Annamalai, K., Ibrahim, H., Kaur, S., Geravandi, S., Sarma, B., Pal, A., Awal, S., Joshi, A., Rafizadeh, S., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109490 · Cited by 32
The Peroxide Dilemma: Opposing and Mediating Insulin Action
Szypowska, A. A., & Burgering, B. M. T. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3794 · Cited by 31
“For example, p27 kip1-/- mice show increased b -cell proliferation and suppressed hyperglycemia, whereas p27 kip1 overexpression resulted in severe diabetes (80).”
Cummins, T. D., Barati, M. T., Coventry, S. C., Salyer, S. A., Klein, J. B., & Powell, D. W. (2009) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2009.09.029 · Cited by 32
Slow and steady is the key to β‐cell replication
Brennand, K., & Melton, D. A. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00635.x · Cited by 34
“Overexpression of p27 specifically in -cells causes hyperglycaemia by four weeks of age and markedly reduced islet mass by 8 weeks of age, while deletion of the p27kip1 gene (Cdkn1b ) ameliorates diabetes by increasing islet mass in both Irs2 /– and Lepr /– mice [48].”
BackgroundInfluentialDiminished Pancreatic β-Cell Mass in Securin-Null Mice Is Caused by β-Cell Apoptosis and Senescence
Chesnokova, V., Wong, C., Zonis, S., Gruszka, A., Wawrowsky, K., Ren, S.-G., BenShlomo, A., & Yu, R. (2009) · Endocrinology · doi:10.1210/en.2008-0972 · Cited by 29
Arumugam, R., Fleenor, D. E., Lu, D., & Freemark, M. (2011) · Endocrinology · doi:10.1210/en.2010-1258 · Cited by 29
“Conversely, KO mutations in p27 increase -cell proliferation in IRS-2 KO mice (60) and are associated with development of human insulin secreting tumors (61, 62), whereas deletions of p57 are associated with neonatal hyperinsulinism (63).”
Metabolic Contributions of Wnt Signaling: More Than Controlling Flight
Azar, F. A., & Lim, G. E. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.709823 · Cited by 29
Stein, J. M., Milewski, W. M., Hara, M., Steiner, D. F., & Dey, A. (2011) · Islets · doi:10.4161/isl.3.1.14435 · Cited by 28
Schaffer, A. E., Yang, A., Thorel, F., Herrera, P. L., & Sander, M. (2011) · Molecular Endocrinology · doi:10.1210/me.2011-1010 · Cited by 26
Leptin and adiponectin regulate compensatory beta cell growth in accordance to overweight
Huypens, P. (2006) · Medical Hypotheses · doi:10.1016/j.mehy.2006.09.046 · Cited by 30
“The adipokine not only prevents loss of existing beta cells [18,19], but also stimulates beta cell proliferation by promoting the nuclear exclusion of p27/Kip1 [20].”
BackgroundSenescence and Type 2 Diabetic Cardiomyopathy: How Young Can You Die of Old Age?
Henson, S. M., & Aksentijević, D. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.716517 · Cited by 25
“In transgenic models of T2D, the cell cycle inhibitor p27 (a marker of senescence) increases in pancreatic β cells, and p27 deletion increased insulin secretion and isletmass through increased proliferation (Uchida et al., 2005).”
BackgroundMapping the Epistatic Network Underlying Murine Reproductive Fatpad Variation
Jarvis, J. P., & Cheverud, J. M. (2010) · Genetics · doi:10.1534/genetics.110.123505 · Cited by 23
“…lipoprotein receptor-related protein that is thought to contribute to variation in a variety of metabolic risk factors in humans (Kahn et al. 2007; Mani et al. 2007) and Cdkn1b, a cyclin-dependent kinase inhibitor with known effects on pancreatic islet mass in diabetic mice (Uchida et al. 2005).”
BackgroundMouse Models of Cell Cycle Regulators: New Paradigms
Aleem, E. A., & Kaldis, P. (2006) · Springer eBooks · doi:10.1007/400_023 · Cited by 25
Radziszewska, A., Schroer, S. A., Choi, D., Tajmir, P., Radulovich, N., Ho, J. C., Wang, L., Liadis, N., Hakem, R., Tsao, M.-S., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806960200 · Cited by 22
Definition of a Skp2-c-Myc Pathway to Expand Human Beta-cells
Tiwari, S., Roel, C., Tanwir, M., Wills, R. C., Perianayagam, N., Wang, P., & Fiaschi‐Taesch, N. (2016) · Scientific Reports · doi:10.1038/srep28461 · Cited by 21
Blandino-Rosano, M., Alejandro, E. U., Sathyamurthy, A., Scheys, J. O., Gregg, B. S., Chen, A. Y., Rachdi, L., Weiss, A., Barker, D. J., Gould, A. P., et al. (2012) · Diabetologia · doi:10.1007/s00125-012-2465-9 · Cited by 21
“in the regulation of the beta cell cycle is not completely understood [26–28].”
Insulin Receptor Substrate-2 in β-Cells Decreases Diabetes in Nonobese Diabetic Mice
Norquay, L., D’Aquino, K. E., Opare-Addo, L., Kuznetsova, A., Haas, M., Bluestone, J. A., & White, M. F. (2009) · Endocrinology · doi:10.1210/en.2009-0395 · Cited by 22
Self-citationCDK4, pRB and E2F1: connected to insulin
Fajas, L., Blanchet, É., & Annicotte, J. (2010) · Cell Division · doi:10.1186/1747-1028-5-6 · Cited by 24
“Conversely, mice with gene inactivation of the cell cycle inhibitors p27 [21,22], p16”
BackgroundKim, C., Jeong, D. E., Heo, S., Ji, E., Rho, J. G., Jung, M., Ahn, S., Kim, Y., Kim, Y., Nam, S. W., et al. (2018) · The Journal of Pathology · doi:10.1002/path.5135 · Cited by 22
“p27 functions as the primary inhibitor of cell cycle progression and proliferation in pancreatic endocrine cells, especially pancreatic β cells [16,37], and attenuated expression of p27 in MENs is associated with malignant pancreatic NETs [5,6,9], implying that loss of p27 might be one of the defects present in benign…”
BackgroundIncreased ribosomal biogenesis induces pancreatic β cell failure in mice model of type 2 diabetes
Asahara, S., Matsuda, T., Kido, Y., & Kasuga, M. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.02.047 · Cited by 19
Self-citationCharoenphandhu, N., Suntornsaratoon, P., Sa‐nguanmoo, P., Tanajak, P., Teerapornpuntakit, J., Aeimlapa, R., Chattipakorn, N., & Chattipakorn, S. C. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2018.01.006 · Cited by 20
Systemic and renal growth hormone–IGF1 axis involvement in a mouse model of type 2 diabetes
Segev, Y., Eshet, R., Yakir, O., Haim, N., Phillip, M., & Landau, D. (2007) · Diabetologia · doi:10.1007/s00125-007-0663-7 · Cited by 20
“The result of these changes may be a decrease in circulating IGF1 and IGF1 action, which may by itself be a mechanism for decreased beta cell survival in long-term type 2 diabetes mellitus [18, 19].”
The potential therapeutic effects of Panax notoginseng in osteoporosis: A comprehensive review
Zhu, Z., Bai, Z., Cui, Y., Li, X., & Zhu, X. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.156703 · Cited by 21
Tamaki, M., Fujitani, Y., Uchida, T., Hirose, T., Kawamori, R., & Watada, H. (2010) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2010.00044.x · Cited by 19
“Similar results were reported previously by Uchida et al.45, whereas some other studies reported a substantial number of apoptotic cells in islets of db/db mice14.”
ResultSelf-citationMatsuda, T., Takahashi, H., Mieda, Y., Shimizu, S., Kawamoto, T., Matsuura, Y., Takai, T., Suzuki, E., Kanno, A., Kimura-Koyanagi, M., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0130757 · Cited by 22
“Quantitation of beta cell mass was performed as described previously [13].”
Self-citationToward a cell‐based cure for diabetes: advances in production and transplant of beta cells
Claiborn, K. C., & Stoffers, D. A. (2008) · Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20058 · Cited by 19
Regeneration of pancreatic beta cells
Jun, H. (2008) · Frontiers in bioscience · doi:10.2741/3145 · Cited by 17
“The CDK inhibitor, p27, is expressed in adult mouse beta cells, and deletion of this gene results in islet hyperplasia (51).”
BackgroundMajer, A. D., Hua, X., & Katona, B. W. (2024) · Genes · doi:10.3390/genes15091231 · Cited by 19
The Akt/FoxO1/p27 pathway mediates the proliferative action of liraglutide in β cells
Li, Y. (2011) · Molecular Medicine Reports · doi:10.3892/mmr.2011.607 · Cited by 23
Charitou, P., & Burgering, B. M. T. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4921 · Cited by 18
“This effect of FOXO is likely through induction of p27 kip1 and reduction of cyclinD, as it has been shown that p27 kip1 - / - mice are protected from diabetes (173).”
β‐Cells at the crossroads: choosing between insulin granule production and proliferation
Liu, Y., Mziaut, H., Ivanova, A., & Solimena, M. (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01107.x · Cited by 20
Miyawaki, K., Inoue, H., Keshavarz, P., Mizuta, K., Sato, A., Sakamoto, Y., Moritani, M., Kunika, K., Tanahashi, T., & Itakura, M. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.06.014 · Cited by 19
González-Pertusa, J. A., Dubé, J. J., Valle, S. R., Rosa, T. C., Takane, K. K., Mellado‐Gil, J. M., Perdomo, G., Vasavada, R. C., & García-Ocaña, A. (2010) · Endocrinology · doi:10.1210/en.2009-0975 · Cited by 16
“Several genetic mouse models have shown that further enhancement of -cell proliferation, survival, and concomitant -cell expansion may improve glucose homeostasis in obesityrelated and insulin resistant conditions (30, 31).”
BackgroundAdipocyte hyperplasia and RMI1 in the treatment of obesity
Suwa, A., Kurama, T., & Shimokawa, T. (2010) · FEBS Journal · doi:10.1111/j.1742-4658.2010.07980.x · Cited by 16
Uresti‐Rivera, E. E., García-Jacobo, R. E., Méndez, J. A. T., Gaytan-Medina, L. E., Cortez-Espinosa, N., Portales‐Pérez, D. P., González‐Amaro, R., Enciso‐Moreno, J. A., & García-Hernández, M. H. (2018) · Gene · doi:10.1016/j.gene.2018.01.084 · Cited by 17
Differential expression of cell cycle proteins during ageing of pancreatic islet cells
Hinault, C., Hu, J., Maier, B. F., Mirmira, R. G., & Kulkarni, R. (2008) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00947.x · Cited by 18
Txnip deficiency promotes β-cell proliferation in the HFD-induced obesity mouse model
Lei, Z., Chen, Y., Wang, J., Zhang, Y., Shi, W., Wang, X., Xing, D., Li, D., & Jiao, X. (2022) · Endocrine Connections · doi:10.1530/ec-21-0641 · Cited by 17
Acteoside as a multifunctional natural glycoside: therapeutic potential across various diseases
Mohammed, R. A., Kamel, A. S. E. D., Hindam, M. O., El‐Dessouki, A. M., Hamouda, H. A., Ramadan, N. M., Mohamed, S. S., El‐Shiekh, R. A., & Kamel, N. M. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-01811-0 · Cited by 18
Insulin resistance in diabetes: The promise of using induced pluripotent stem cell technology
Elsayed, A. K., Vimalraj, S., Nandakumar, M., & Abdelalim, E. M. (2021) · World Journal of Stem Cells · doi:10.4252/wjsc.v13.i3.221 · Cited by 16
“inhibition in the β-cell function [106,134].”
Hepatocyte Growth Factor Ameliorates Hyperglycemia and Corrects β-Cell Mass in IRS2-Deficient Mice
Álvarez-Pérez, J. C., Rosa, T. C., Casinelli, G. P., Valle, S. R., Lakshmipathi, J., Rosselot, C., Rausell-Palamos, F., Vasavada, R. C., & García-Ocaña, A. (2014) · Molecular Endocrinology · doi:10.1210/me.2014-1207 · Cited by 17
Spirulina Reverses Histomorphological Changes in Diabetic Osteoporosis in Pioglitazone Treated Rats
Devesh, C. (2012) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.s1-006 · Cited by 14
“The third probable mechanism suggests that insulin inactivate p27, a cyclin-dependent kinase inhibitor that could attenuate cell proliferation in osteoblasts [45-47].”
Background4E-BP2/SH2B1/IRS2 Are Part of a Novel Feedback Loop That Controls β-Cell Mass
Blandino-Rosano, M., Scheys, J. O., Jiménez-Palomares, M., Barbaresso, R., Bender, A. S., Yanagiya, A., Liu, M., Rui, L., Sonenberg, N., & Bernal‐Mizrachi, E. (2016) · Diabetes · doi:10.2337/db15-1443 · Cited by 15
“The role of the IRS2/p27 axis in the modulation of b-cell cycle progression has been well-established previously (42).”
BackgroundGiovos, G., Yavropoulou, M. P., & Yovos, J. G. (2019) · HORMONES · doi:10.1007/s42000-019-00132-6 · Cited by 17
“The p27 cell cycle inhibitor increases in pancreatic β-cells in type 2 DM mouse models, and the deletion of p27 in these mice restores insulin secretion and β-cell mass [59].”
BackgroundBahour, N., Bleichmar, L., Abarca, C., Wilmann, E., Sanjines, S., & Aguayo‐Mazzucato, C. (2023) · Aging · doi:10.18632/aging.204483 · Cited by 16
“Additionally, it has been reported that p27 loss is associated with increased β-cell proliferation and mass after HFD or leptin receptor loss [35, 36].”
Stein, J. M., Milewski, W. M., & Dey, A. (2013) · Islets · doi:10.4161/isl.25605 · Cited by 15
“Deletion of the gene encoding p27(Kip1) in animal models of insulin resistance (type 2 diabetes) results in amelioration of hyperglycemia by stimulating pancreatic β-cell proliferation and increasing β-cell mass.(2) Studies using Skp2 knockout mice demonstrate the critical importance of p27(Kip1) degradation in adult…”
BackgroundChlorogenic Acid and Caffeine in Coffee Restore Insulin Signaling in Pancreatic Beta Cells.
Ihara, Y., Asahara, S., Inoue, H., Seike, M., Ando, M., Kabutoya, H., Kimura-Koyanagi, M., & Kido, Y. (2023) · PubMed Central · doi:10.24546/0100480554 · Cited by 22
Self-citationIncreasing β-Cell Mass Requires Additional Stimulation for Adaptation to Secretory Demand
Mondal, P., Song, W., Li, Y., Yang, K. S., & Hussain, M. A. (2014) · Molecular Endocrinology · doi:10.1210/me.2014-1265 · Cited by 14
Deletion of the Men1 Gene Prevents Streptozotocin-Induced Hyperglycemia in Mice
Yang, Y., Wang, H., & Hua, X. (2010) · Experimental Diabetes Research · doi:10.1155/2010/876701 · Cited by 13
Huang, R., Lu, Y., Xie, Z., Yang, X., & Ou, Y. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120907 · Cited by 11
Ahn, C. H., Choi, E. H., Oh, T. J., & Cho, Y. M. (2020) · Obesity Surgery · doi:10.1007/s11695-020-04406-6 · Cited by 11
“Genetic ablation of senescent cells through knock-out of p27 ameliorated hyperglycemia in ob/ob mice [17].”
BackgroundRapamycin Inhibits Growth Factor-Induced Cell Cycle Regulation in Pancreatic β Cells
Aronovitz, A., Josefson, J. L., Fisher, A. D., Newman, M. V., Hughes, E., Chen, F., Moons, D. S., Kiyokawa, H., & Lowe, W. L. (2008) · Journal of Investigative Medicine · doi:10.2310/jim.0b013e31818ce763 · Cited by 15
“A recent study demonstrated that IGF-I stimulates the nuclear export of p27 in pancreatic "-cells, although the signaling pathway mediating this effect of IGF-I was not defined.(51) Previous studies have demonstrated an effect of rapamycin on insulin secretion as well as vascular endothelial growth factor production a…”
BackgroundNam, S. Y., Lee, M. K., & Sabapathy, K. (2007) · The Journal of Physiology · doi:10.1113/jphysiol.2007.142612 · Cited by 13
“have been used to confirm their role in β cell death and dysfunction in type-2 diabetic models (Oyadomari et al. 2002; Uchida et al. 2005).”
BackgroundMethodDamarov, I. S., Korbolina, E. E., RYKOVA, E. Y., & Merkulova, T. I. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179297 · Cited by 14
“…TKT [54], and CCDC92 [48]); insulin secretion ( GIPR [56], KCNJ15 [57], and AP3S2 [58], ARAP1 [59]); proliferation of pancreatic β -cells ( CDKN1B [60] and CCND2 [61]); mitophagy ( TP53INP1 [53]); glycolysis ( TKT [54]); and carbohydrate transport ( GBA2 [62]). and a certain phenotypic trait…”
BackgroundAntifouling Hydrogel Based on Zwitterionic Poly(carboxybetaine diacrylate) Cross-Linkers
Li, C., Gao, D., Zhang, L., Li, J., Zhang, F., Han, X., & Cheng, G. (2025) · Langmuir · doi:10.1021/acs.langmuir.4c04515 · Cited by 10
Yang, J.-G., Deng, Y., Zhou, L., Li, X., Sun, P., & Sun, N.-X. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-10176 · Cited by 13
Diabetes Mellitus: An Opportunity for Therapy with Stem Cells?
Sordi, V., Bertuzzi, F., & Piemonti, L. (2008) · Regenerative Medicine · doi:10.2217/17460751.3.3.377 · Cited by 12
Wiedemann, T., Bielohuby, M., Müller, T. D., Bidlingmaier, M., & Pellegata, N. S. (2015) · Diabetes · doi:10.2337/db15-0374 · Cited by 10
“Previous studies on type 2 diabetic db/db mice showed that deletion of the gene encoding p27 ameliorated hyperglycemia by increasing pancreatic islet mass and maintaining compensatory hyperinsulinemia, effects that were attributable to the stimulation of pancreatic b-cell proliferation (23,25).”
BackgroundIwatani, Y., Hayashi, H., Yamamoto, H., Minamikawa, H., Ichikawa, M., Orikawa, H., Masuda, A., Tada, N., Moriyama, Y., & Takagi, N. (2023) · Experimental Neurology · doi:10.1016/j.expneurol.2023.114584 · Cited by 8
CEBPA Overexpression Enhances β-Cell Proliferation and Survival
Ellsworth, P. N., Herring, J. A., Leifer, A. H., Ray, J. D., Elison, W. S., Poulson, P. D., Crabtree, J. E., Ry, P. M. V., & Tessem, J. S. (2024) · Biology · doi:10.3390/biology13020110 · Cited by 9
Aitken, T. J., Crabtree, J. E., Jensen, D. M., Hess, K. H., Leininger, B., & Tessem, J. S. (2021) · Biology of the Cell · doi:10.1111/boc.202100035 · Cited by 9
“Various studies have demonstrated that p27KIP1 overexpression decreases β-cell proliferation and islet mass, and that p27KIP1 deletion results in greater β-cell proliferation and islet mass (Georgia & Bhushan, 2006; Rachdi et al., 2006; Stein et al., 2013; Uchida et al., 2005).”
BackgroundWang, H., Shan, B., Duan, Y., Zhu, J. L., Jiang, L., Liu, Y., Zhang, Y., Qi, F., & Niu, S. (2020) · Pharmaceutical Biology · doi:10.1080/13880209.2020.1839511 · Cited by 7
“When the insulin/IGF signalling pathway is activated, IRS1/2 is activated first, followed by the PI3K/AKT signalling pathway, resulting in the upregulation of Bcl-2 gene expression and regulation of the cell cycle to promote cell proliferation (Uchida et al. 2005; Liu et al. 2010).”
BackgroundPresent Accomplishments and Future Prospects of Cell-Based Therapies for Type 1 Diabetes Mellitus
Chhabra, P., Clark, D. L., Daniel, J., & Kenneth, L. B. (2011) · InTech eBooks · doi:10.5772/22343 · Cited by 10
Li, M., Zhang, R., Ge, Q., Yue, L., Ma, D., Khattab, F., Xie, W., Cui, Y., Gilon, P., Zhao, X., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119136 · Cited by 7
“In addition, leptin was involved in PTEN inhibition, thereby upregulating β cell proliferation through activating cyclin-dependent kinase in db/db mice [40].”
BackgroundPancreatic cells and their progenitors.
Salpeter, S., & Dor, Y. (2006) · Methods in Enzymology · doi:10.1016/s0076-6879(06)19013-8 · Cited by 5
LXR activation causes G1/S arrest through inhibiting SKP2 expression in MIN6 pancreatic beta cells
Li, Y., Jing, C., Tang, X., Chen, Y., Han, X., & Zhu, Y. (2016) · Endocrine · doi:10.1007/s12020-016-0915-8 · Cited by 5
Age-Dependent Onset of Insulin Resistance in Insulin-Resistant Mice
Ide, N., Arisawa, K., Ogura, K., Kagawa, Y., & Maeda, T. (2015) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b15-00602 · Cited by 4
Bonal, C., & Herrera, P. L. (2007) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e3280129669 · Cited by 5
[The effect of deep branches of cervical nerve on motorial function of trapezius muscle].
Wang, F., Wen, Y., & Li, L. (2003) · 华西口腔医学杂志 · Cited by 4
Li, J., Huang, Q., Nie, Q., Luo, Y., Zeng, H., Zhang, Y., He, X., & Liu, J. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e32460 · Cited by 6
“Additionally, Lockd positively regulates the transcription of cyclin-dependent kinase inhibitor 1B (CDKN1B) through an enhancer-like cis -element [26], which has been reported to be involved in insulin secretion and glucose metabolism [27].”
BackgroundNoncanonical CDK4 signaling rescues diabetes in a mouse model by promoting β cell differentiation
Stamateris, R. E., Landa-Galván, H. V., Sharma, R. B., Darko, C., Redmond, D., Rane, S. G., & Alonso, L. C. (2023) · Journal of Clinical Investigation · doi:10.1172/jci166490 · Cited by 4
“1172/JCI166490 a Cip/Kip cell cycle inhibitor, is a cause of β cell failure in IRS2-null mice (80).”
BackgroundIwatani, Y., Hayashi, H., Minamisawa, M., Hasegawa, S., Moriyama, Y., & Takagi, N. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118963 · Cited by 3
Metabolic and physiological effects of insulin
Gupta, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820234-0.00007-x · Cited by 3
Pancreatic beta cell mass preserved in heterozygous PDK1 knockout mice.
Takeda, A., Kido, Y., Hashimoto, N., Noda, T., & Kasuga, M. (2008) · PubMed · Cited by 2
Self-citationSignificance of Organ Crosstalk in Insulin Resistance and Type 2 Diabetes
Bhatt, S., & Kulkarni, R. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-415784-2.00017-8 · Cited by 3
Osteocalcin: the relationship between bone metabolism and glucose homeostasis in diabetes mellitus
Ковальчук, А., Zinych, О. В., Korpachev, V. V., Кushnareva, N. M., Prybyla, О. В., & Shyshkan-Shyshova, К. О. (2021) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.17.4.2021.237347 · Cited by 3
Pancreatic β-Cell Senescence: Mechanisms and Association with Diabetes
Ahmed, S. M., Elshenawy, S. E., Sedky, S., Elmehrath, A. O., & El‐Badri, N. (2021) · European Medical Journal · doi:10.33590/emj/20-00128 · Cited by 5
Aging and Cardiovascular Diseases: The Role of Cellular Senescence
Bozaykut, P. (2019) · Springer eBooks · doi:10.1007/978-981-13-8273-4_10 · Cited by 3
Maximizing endogenous β-cell regeneration
Crutchlow, M. F., & Stoffers, D. A. (2007) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e328012b281 · Cited by 2
Distinct Molecular Mechanisms Analysis of Obesity Based on Gene Expression ProfilesPreprint
Joshi, H. R., Vastrad, B. M., Joshi, N., & Vastrad, C. M. (2020) · doi:10.21203/rs.3.rs-95029/v1 · Cited by 2
Jetton, T. L., Gupta, D., & Peshavaria, M. (2011) · Humana Press eBooks · doi:10.1007/978-1-60327-256-8_3 · Cited by 1
Effects of Sodium–Glucose Cotransporter 2 Inhibitors on Calcium Homeostasis: Where We Stand Now
Cuttone, A., Xourafa, A., Morace, C., Cannavò, V., Bueti, F. M., Mandraffino, G., Squadrito, G., Basile, G., Gaudio, A., Catalano, A., et al. (2025) · Cells · doi:10.3390/cells14100724 · Cited by 3
Nr4a1 β-cell specific deletion impairs glucose tolerance in female mice
Herring, J. A., Wynn, A. G., Aitken, T. J., Walker, N. D., Whalen, K. E., & Tessem, J. S. (2025) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00207.2024 · Cited by 2
Pancreatic β-Cell Senescence: A Contributor to Type 2 Diabetes
Urmi, R., Singh, R., Singh, M., & Sinha, B. K. (2025) · Springer eBooks · doi:10.1007/978-981-96-1041-9_8 · Cited by 1
c-Myc, Apoptosis, and Disordered Tissue Growth
Khan, M., & Pelengaris, S. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-200-7_6 · Cited by 2
Búsqueda de dianas terapeúticas en la célula Beta-Pancreática para el tratamiento de la diabetes
Acosta, J. F. L. (2013) · UVaDOC UVaDOC University of Valladolid Documentary Repository (University of Valladolid) · doi:10.35376/10324/4374 · Cited by 2
Zhang, J. A., Gu, C., Smith, D. K., Kong-Beltran, M., Kljavin, N. M., Ngu, H., Suriben, R., Stinson, J., Modrusan, Z. D., & Peterson, A. S. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/303263 · Cited by 1
“Harnessing the adaptive responses of β cells has been proposed as an attractive approach to treat both T1D and T2D (Uchida et al. 2005; Butler et al. 2007; Nir et al. 2007; Linnemann et al. 2014; Cheng et al. 2017).”
BackgroundComstock, S. M. (2000) · doi:10.15760/etd.551
“Total islet area, islet mass [(total islet area/pancreas area)x pancreas weight], and β and α cell mass [(total cell area/pancreas area)x pancreas weight] were calculated as previously reported (Uchida et al., 2005).”
MethodCell Cycle Regulation in Human Pancreatic Beta Cells
Fiaschi‐Taesch, N., Harb, G., Karsiloglu, E., Takane, K. K., & Stewart, A. F. (2009) · Humana Press eBooks · doi:10.1007/978-1-60761-366-4_3
Genetic Control of β-Cell Mass Homeostasis
Tyrberg, B. (2010) · The Open Endocrinology Journal · doi:10.2174/1874216501004010011
“Deleting the cell cycle inhibitory kinase p27 Kip1 rescued diabetes and loss of -cell mass in BKS-db mice [78].”
BackgroundStaffa, J. (2013) · Elektronische Hochschulschriften der LMU München (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.16276
Role of IGF-I in Type 2 diabetes: a focus on the mouse model
Landau, D., & Segev, Y. (2007) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.3.1.43
Gonzalez, S., & Burks, D. J. (2009) · Avances en Diabetología
Salpeter, S. J., & Dor, Y. (2008) · Springer eBooks · doi:10.1007/978-4-431-75452-7_13
Kasuga, M. (2007) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.96.1836
Self-citation
Metadata
- Authors
- Uchida, T., Nakamura, T., Hashimoto, N., Matsuda, T., Kotani, K., Sakaue, H., Kido, Y., Hayashi, Y., Nakayama, K. I., White, M. F., & Kasuga, M.
- Affiliations
- Kobe University (JP)
- Kyushu University (JP)
- Joslin Diabetes Center (US)
- Corresponding author
- Kasuga, Masato
- ORCID
- Venue
- Nature Medicine
- Published
- 2005-01-30
- Volume
- 11
- Issue
- 2
- Pages
- 175-182
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2151058113
- Cited by
- 218
- References
- 48
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 6 · 2023: 6 · 2022: 5 · 2021: 10 · 2020: 4 · 2019: 4 · 2018: 9 · 2017: 4 · 2016: 4 · 2015: 6 · 2014: 8 · 2013: 9 · 2012: 13
- FWCI
- 21.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- p27, type 2 diabetes, hyperglycemia, compensatory hyperinsulinemia, pancreatic beta cells, beta-cell proliferation, beta-cell failure, insulin receptor substrate 2, leptin receptor, db/db mice, islet mass, cyclin-dependent kinase inhibition
- MeSH terms
- Animals, Cell Nucleus, Diabetes Mellitus, Type 2, Disease Models, Animal, Enzyme Inhibitors, Hyperglycemia, Hyperinsulinism, Insulin-Like Growth Factor I, Islets of Langerhans, Phosphoproteins, Proto-Oncogene Proteins, Receptors, Cell Surface, Signal Transduction, Protein Serine-Threonine Kinases, Mice, Knockout, Cell Cycle Proteins, Leptin, Tumor Suppressor Proteins, Intracellular Signaling Peptides and Proteins, Cyclin-Dependent Kinase Inhibitor p27, Proto-Oncogene Proteins c-akt, Mice, Receptors, Leptin, Insulin Receptor Substrate Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.